发明申请
US20050196459A1 Carvedilol salts, anhydrates and/or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
有权
卡维地洛盐,其水合物和/或溶剂合物,相应的药物组合物,控制释放制剂和治疗或递送方法
- 专利标题: Carvedilol salts, anhydrates and/or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
- 专利标题(中): 卡维地洛盐,其水合物和/或溶剂合物,相应的药物组合物,控制释放制剂和治疗或递送方法
-
申请号: US10996780申请日: 2004-11-24
-
公开(公告)号: US20050196459A1公开(公告)日: 2005-09-08
- 发明人: Catherine Castan , Florence Guimberteau , Remi Meyrueix , Gerard Soula
- 申请人: Catherine Castan , Florence Guimberteau , Remi Meyrueix , Gerard Soula
- 申请人地址: US DC Washington
- 专利权人: Flamel Technologies S.A.
- 当前专利权人: Flamel Technologies S.A.
- 当前专利权人地址: US DC Washington
- 主分类号: A61K
- IPC分类号: A61K20060101 ; A61K9/16 ; A61K9/22 ; A61K9/50 ; A61K31/403
摘要:
The field of the invention is that of oral pharmaceutical medicinal products or compositions, more particularly of the type of those comprising one or more active principles. The aim of the invention is to provide an improved oral medicinal product that can be administered in one or more daily doses, with modified release of active principle (in particular an active principle), for improving the prophylactic and therapeutic efficacy of such a medicinal product. This aim is achieved by means of the multimicrocapsular oral pharmaceutical form according to the invention in which the release of the AP is controlled by means of a double mechanism of triggering the release: “time triggering” and “pH triggering”. This medicinal product comprises microcapsules with modified release of active principle, each containing a core comprising the active principle and one or more swelling agents, and at least one coating making possible the modified release of the active principle.
公开/授权文献
信息查询